Globus Medical to Exhibit Latest Advancements in MIS Spine Surgery at SMISS Annual Forum
August 29 2018 - 8:30AM
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal
solutions company, will feature its ExcelsiusGPS® revolutionary
robotic guidance and navigation system along with its latest
advancements in expandable interbody technology at the Society for
Minimally Invasive Spine Surgery (SMISS) Annual Forum being held
September 6-8, 2018, in Las Vegas, Nevada.
As part of the Forum’s scientific agenda, two clinical studies
will be presented highlighting Globus Medical’s expandable lateral
interbody spacer technology designed to restore disc height,
increase lordosis, and reduce subsidence compared to traditional
static spacers. The company will also host an ExcelsiusGPS®
workshop presented by Dr. Sabino D’Agostino, a neurosurgeon from
South Carolina, who will discuss his transition to the
ExcelsiusGPS® platform and the impact it has had on his minimally
invasive spine surgery procedures.
“As leaders in the musculoskeletal device industry, we are
committed to supporting research, education, and development of
medical advancements through minimally invasive spine surgery,”
said Andrew Iott, Senior Vice President, Global Product
Development. “We are proud to be a sponsor of SMISS and are excited
to showcase our state-of-the-art ExcelsiusGPS® robotic system and
best-in-class platform of innovative expandable implants for MIS
spine surgery.”
Globus welcomes SMISS attendees to clinical presentations and
workshops on Friday, September 7.
7:30am:
Pompeian III/IVExcelsiusGPS® First
Clinical ExperienceSabino D’Agostino, MD; Charleston Brain
and Spine, Charleston, SC11:05am: Florentine BallroomA
Clinical Study to Evaluate Static versus Expandable Lateral Lumbar
Interbody Fusion Devices: With One-year Follow-up Richard
Frisch, MD; Southeastern Spine Institute, Mount Pleasant,
SC11:17am: Florentine BallroomDo Expandable Cages Lead to a
Higher Incidence of Subsidence? Two-year Follow-up of Lateral
Lumbar Interbody Fusions Dan Cohen, MD; Spine Care
Institute of Miami Beach, Miami Beach, FL |
|
Globus Medical invites meeting attendees to Booth# 201 to
experience its most recent product innovations and discuss MIS
advancements.
About Globus Medical, Inc.Globus Medical, Inc.
is a leading musculoskeletal solutions company based in Audubon,
PA. The company was founded in 2003 by an experienced team of
professionals with a shared vision to create products that enable
surgeons to promote healing in patients with musculoskeletal
disorders. Additional information can be accessed
at http://www.globusmedical.com.
Safe Harbor StatementsAll statements included
in this press release other than statements of historical fact are
forward-looking statements and may be identified by their use of
words such as “believe,” “may,” “might,” “could,” “will,” “aim,”
“estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan”
and other similar terms. These forward-looking statements are based
on our current assumptions, expectations and estimates of future
events and trends. Forward-looking statements are only predictions
and are subject to many risks, uncertainties and other factors that
may affect our businesses and operations and could cause actual
results to differ materially from those predicted. These risks and
uncertainties include, but are not limited to, factors affecting
our quarterly results, our ability to manage our growth, our
ability to sustain our profitability, demand for our products, our
ability to compete successfully (including without limitation our
ability to convince surgeons to use our products and our ability to
attract and retain sales and other personnel), our ability to
rapidly develop and introduce new products, our ability to develop
and execute on successful business strategies, our ability to
comply with changing laws and regulations that are applicable to
our businesses, our ability to safeguard our intellectual property,
our success in defending legal proceedings brought against us,
trends in the medical device industry, general economic conditions,
and other risks. For a discussion of these and other risks,
uncertainties and other factors that could affect our results, you
should refer to the disclosure contained in our most recent annual
report on Form 10-K filed with the Securities and Exchange
Commission, including the sections labeled “Risk Factors” and
“Cautionary Note Concerning Forward-Looking Statements,” and in our
Forms 10-Q, Forms 8-K and other filings with the Securities and
Exchange Commission. These documents are available at www.sec.gov.
Moreover, we operate in an evolving environment. New risk factors
and uncertainties emerge from time to time and it is not possible
for us to predict all risk factors and uncertainties, nor can we
assess the impact of all factors on its business or the extent to
which any factor, or combination of factors, may cause actual
results to differ materially from those contained in any
forward-looking statements. Given these risks and uncertainties,
readers are cautioned not to place undue reliance on any
forward-looking statements. Forward-looking statements contained in
this press release speak only as of the date of this press release.
We undertake no obligation to update any forward-looking statements
as a result of new information, events or circumstances or other
factors arising or coming to our attention after the date
hereof.
Contact:Brian KearnsVice President, Business
Development and Investor RelationsPhone: (610) 930-1800Email:
investors@globusmedical.comwww.globusmedical.com
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Apr 2023 to Apr 2024